18.55
Sarepta Therapeutics Inc (SRPT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
17.96%
611.09
|
744.86 | 658.41 | 467.17 | 362.93 |
|
52.59%
495.51
|
1,045.24 | 496.73 | 444.98 | 363.63 |
Interest Income/Expense |
216.10%
5.228
|
-4.503 | -32.31 | 4.918 | 4.832 |
Benefits Costs and Expenses |
59.46%
457.45
|
1,128.37 | 486.67 | 433.17 | 349.35 |
Costs And Expenses |
52.59%
495.51
|
1,045.24 | 496.73 | 444.98 | 363.63 |
Operating Income/Loss |
138.48%
115.58
|
-300.39 | 161.68 | 22.20 | -0.701 |
Nonoperating Income/Loss |
145.78%
38.06
|
-83.13 | 10.06 | 11.81 | 14.28 |
Income/Loss From Continuing Operations Before Tax |
140.06%
153.64
|
-383.52 | 171.74 | 34.01 | 13.58 |
Income Tax Expense/Benefit |
167.59%
-43.25
|
63.99 | 12.69 | 0.395 | 7.117 |
Income/Loss From Continuing Operations After Tax |
144.00%
196.89
|
-447.51 | 159.05 | 33.61 | 6.46 |
|
144.00%
196.89
|
-447.51 | 159.05 | 33.61 | 6.46 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.66%
98.00
|
97.36 | 0.406 | 95.39 | 94.62 |
Diluted Average Shares |
9.51%
106.62
|
97.36 | 8.303 | 100.45 | 99.14 |
Basic Earnings Per Share |
143.70%
2.01
|
-4.60 | 1.67 | 0.35 | 0.07 |
Diluted Earnings Per Share |
141.09%
1.89
|
-4.60 | 1.56 | 0.34 | 0.07 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):